Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-016915
Filing Date
2013-03-15
Accepted
2013-03-15 16:49:33
Documents
1
Period of Report
2013-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4178
  Complete submission text file 0001209191-13-016915.txt   5523
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Issuer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Schroeder Theodore R (Reporting) CIK: 0001378690 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33103 | Film No.: 13694755